Key result
Review summarizes optimal angiography timing and non-culprit lesion treatment strategies in ACS.
Why the study?
The optimal timing of coronary angiography and the best strategy for treating non-culprit lesions in ACS patients with multivessel disease remain controversial and undetermined.
What is the optimal timing for coronary angiography and the best strategy for treatment of non-culprit lesions in patients with acute coronary syndromes?
What is the optimal timing for coronary angiography and the best strategy for treatment of non-culprit lesions in patients with acute coronary syndromes?
This review discusses the optimal timing of coronary angiography and strategies for treating non-culprit lesions in patients with acute coronary syndromes.
Answers are grounded in this paper and cite their sources.
Review summarizes ACS angiography timing and non-culprit strategies without new data; leaves open need for prospective trials.
### Learning objectives #### Patients presenting with non-ST-segment elevation acute coronary syndrome (NSTEACS) #### Patients presenting with ST-segment elevation myocardial infarction (STEMI) #### Patients presenting with cardiogenic shock Acute coronary syndrome (ACS) represents one of the primary causes of mortality and loss of disability-adjusted life years worldwide despite recent pharmacological and technological innovations.1 Percutaneous coronary intervention (PCI) of the culprit vessel remains the standard of care for patients presenting with ACS.1 Nevertheless, multivessel coronary disease is found in up to 60% of patients presenting with ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation acute coronary syndrome (NSTEACS), and is associated with worse clinical outcomes and increased mortality.2 The optimal timing to undergo coronary angiography and the best strategy for treatment of non-culprit lesions have been subject to controversies for the past two decades and are yet to be determined. Therefore, the aim of this article was …
No takes yet. Share an insight, caveat, or question.
Sanz‐Sánchez et al. (2021) conducted a review in Acute coronary syndromes. Timing and completeness of revascularisation was evaluated. This article reviews the optimal timing for coronary angiography and strategies for treating non-culprit lesions in patients with acute coronary syndromes, with no quantitative results reported.
Synapse has enriched 10 related papers. Consider them for comparative context: